Otero Rosiles Adrian 4

What Happened
Adrian Otero Rosiles, CEO, is reported as acquiring 22,500 ordinary shares through a private placement tied to the closing of the underwriters' over‑allotment option. The Sponsor purchased 22,500 units at $10.00 per unit (each unit = 1 ordinary share + a right to receive 0.1 ordinary share on completion of an initial business combination), for an aggregate purchase price of $225,000. The Form 4 lists the transaction as a purchase (code P); the filing lists the per‑share price as N/A because the acquisition was of units in a private placement.

Key Details

• Transaction date: May 6, 2026 (reported on Form 4 filed May 6, 2026) — filing appears timely.
• Reported shares acquired: 22,500 ordinary shares (part of 22,500 private units).
• Price/total: $10.00 per unit; aggregate $225,000 for the private units.
• Ownership after transaction: shares held directly by West Enclave Sponsor LLC; beneficial ownership attributed indirectly to Emilio Mahuad and Adrian Otero as controllers of the Sponsor. The filing notes each disclaims beneficial ownership except to the extent of pecuniary interest.
• Footnotes: F1 explains over‑allotment closing and private unit purchase details; F2 explains holdings are held by Sponsor and indirectly controlled by Mr. Mahuad and Mr. Otero.

Context
This was a sponsor private placement made simultaneously with the exercise/closing of the IPO over‑allotment — a common post‑IPO sponsor purchase rather than an open‑market personal buy. Because the securities are held by the Sponsor and the insiders disclaim direct beneficial ownership (other than any economic interest), this transaction reflects the Sponsor’s placement terms and not necessarily a personal investment decision by the CEO.